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Abstract—The epoxide hydrolase (EH) from Agrobacterium radiobacter AD1 wild type (ArWT) and its Tyr215Phe mutant were compared
for the biocatalyzed hydrolytic kinetic resolution (BHKR) of 2-, 3- and 4-pyridyloxirane. The regioselectivity of the oxirane ring opening as
well as the substrate concentration limit and the inhibitory effect of the diol were determined. A gram scale preparation of enantiopure
2-pyridyloxirane (ee.98%) at a concentration as high as 127 mM (15.5 g/L) could be achieved with each of these two enzymes. q 2001
Elsevier Science Ltd. All rights reserved.
1. Introduction
In recent years, epoxide hydrolases (EHs) (EC 3.3.2.3) have
been shown to be ubiquitous in nature, to be cofactor
independent and to catalyze the enantioselective addition
of water to an epoxide, thus leading to the corresponding
diol and the recovery of the less reactive substrate enan-
tiomer via a biocatalysed hydrolytic kinetic resolution
(BHKR).1–7 One general advantage of this approach is the
fact that it constitutes a typical ‘green chemistry’ process,
which can be run using water as the only solvent and reac-
tant, and only implies a natural and biodegradable catalyst,
i.e. an enzyme. Using such a strategy, both the epoxide and
the diol can be obtained in—ideally—enantiopure form.
Moreover, since this process is a kinetic resolution, it is
generally possible to tune the ee of the remaining epoxide
up to enantiopurity, simply by choosing the appropriate
extent of conversion. Furthermore, combination of enantio-
and regiocomplementary enzymes can, in certain cases,
enable to develop highly valuable enantioconvergent
processes allowing to overcome the 50% yield limitation
intrinsic to a common resolution process. We have for
instance recently illustrated the possible use of a fungal
epoxide hydrolase for the synthesis of enantiomerically
pure bioactive compounds like Ibuprofen8 or Eliprodil.9
This method may be even more attractive if it allows the
preparation of epoxides which cannot be obtained by using
the presently available conventional chemistry approaches.
This is for instance the case for 2-, 3- and 4-pyridyloxirane
1–3,10 which are key-step building blocks for the synthesis
of several biologically active compounds, such as
b-adrenergic receptor antagonists or anti-obesity
drugs.11–13 We have recently shown that these substrates
can be conveniently obtained in enantiopure form using
partially purified EH from Aspergillus niger,14 and were
interested in testing other enzymes in this context. In parti-
cular, some of us have recently isolated, cloned and over-
expressed the epoxide hydrolase from the bacterium
Agrobacterium radiobacter AD1 and studied some of its
enzyme/substrate properties.15–18 Both the A. niger and the
A. radiobacter EHs have recently been crystallized and
their three-dimensional structure has been determined.19,20
Tetrahedron 57 (2001) 2775–2779Pergamon
TETRAHEDRON
0040–4020/01/$ - see front matter q 2001 Elsevier Science Ltd. All rights reserved.
PII: S0040-4020(01)00146-6
Keywords: Agrobacterium radiobacter; epoxide hydrolase; biocatalysed
hydrolytic kinetic resolution.
p Corresponding author. Tel.: 133-4-91-82-91-58; fax: 133-4-91-82-91-
45; e-mail: furstoss@luminy.univ-mrs.fr Scheme 1.
Y. Genzel et al. / Tetrahedron 57 (2001) 2775–27792776
Moreover, a Tyr215Phe mutant of the A. radiobacter
enzyme has been constructed and was shown to exhibit a
substantial improvement of the enantioselectivity (E value)
for (substituted) styrene oxides.17 The experiments
described here were aimed at obtaining kinetic resolution
of 1–3 (Scheme 1) using the wild type A. radiobacter
epoxide hydrolase (ArWT) and its Tyr215Phe mutant.
2. Results and discussion
2.1. Resolution of pyridyloxiranes by wild-type and
mutant A. radiobacter epoxide hydrolase
Previous work has shown that the A. radiobacter epoxide
hydrolase was able to hydrolyze styrene oxide and various
derivatives thereof.15 One of the most intriguing facts is the
existence of a so-called ‘sequential’ mechanism. Thus,
owing to the fact that the KM ratio of the two enantiomers
is very high (KM (S)/KM(R)46), hydrolysis of the (S)-enan-
tiomer is almost completely inhibited by the (R)-enantiomer
as long as the latter has not totally disappeared. After
consumption of the (R)-enantiomer, the (S)-enantiomer is
consumed much faster, due to the fact that its kcat value is
higher than that of the (R) enantiomer (kcat(S)/kcat(R)2.5).
This is evidently an important drawback for the use of such
a catalyst at a preparative scale, since it necessitates to very
accurately tune the extent of conversion of such a BHKR in
order to obtain a reasonable ee/yield compromise. Sur-
prisingly enough, this is no more the case for the mutated
enzyme, where a classical kinetic profile implying a con-
sistent rate difference between the two enantiomers was
observed.17,21 A similar reaction profile was similarly
observed for compounds 1–3 (Fig. 1). Thus, the ArWT
EH again showed a sequential mechanism for all three
substrates, while the Tyr215Phe EH clearly hydrolyzed
one enantiomer much slower than the other one, even
after consumption of the preferred enantiomer.22
This difference in behavior is illustrated by Fig. 1 in the case
of epoxide 1. For both enzymes, the remaining antipode was
of (S)-configuration. At 7 mM substrate concentration, we
observed as expected a significant increase in enantioselec-
tivity for the mutated EH (Table 1).
2.2. Enantio- and regioselectivity determination
Due to the possible combination of enantio- and regioselec-
tivity inherent to epoxide hydrolase catalyzed resolutions,23
the E-values corresponding to the various experiments were
calculated on the basis of the ee of the remaining substrate
and the degree of conversion (Table 1). As expected, the
mutated enzyme exhibited a higher enantioselectivity then
the wild type enzyme towards substrates 1–3. This clearly
confirms that replacement of the active site Tyr215 residue
by a phenylalanine constitutes an important factor for
enhancing the overall enantioselectivity of this epoxide
hydrolase for structurally different substrates.
An epoxide can a priori be attacked at either carbon atom of
the oxirane ring. We therefore determined the a (S)/b (S)
and a (R)/b (R) ratio for 1–3, using the ee of the diol
obtained upon biohydrolysis of the enantiopure (S)-epoxide
and the ee of the diol formed after total conversion of the
racemic epoxide.23 The results obtained for the EH of ArWT
and the Tyr215Phe mutant are summarized in Table 2. No
difference of regioselectivity could be observed between the
wild type and the mutant enzyme, both enzymes showing a
highly preferential attack at the b-carbon atom in all cases.
Since for all three substrates the a (S) and a (R) values were
identical for both enantiomers, racemic diol was formed
upon completion of the reaction (eef0%). However, as
also observed for the A. niger EH,14 the regioselectivity
was found to be a function of the position of the nitrogen
atom and showed a slight increase of the a=b ratio 1 to 3.
Thus, the best regioselectivity was observed for 1, with only
3% of the attack occurring at the a position.
2.3. Inhibition by the diol
Product inhibition can be a serious problem for scaling up
kinetic resolutions. If the product formed is a strong com-
petitive inhibitor, the conversion rate will slow down during
Figure 1. BHKR of 1 (7 mM, 288C, 500 rpm) using the A. radiobacter wild type enzyme (ArWT) (0.02 g/L) or the Tyr215Phe mutant EHs (0.34 g/L).
Table 1. E-values for hydrolysis of 1–3 (5–10 mM) with the ArWT and
Tyr215Phe A. radiobacter EHs
EH-source 1 2 3




The spontaneous hydrolysis of 1 at 288C was estimated to be about 0.005%/
min. Therefore, the E-values given in this table are apparent values, and the
actual enzyme enantioselectivity must be somewhat higher.
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progress of the reaction and thus limit a large-scale con-
version. Inhibition of the activity of Tyr215Phe mutant
EH by diol 1d was determined by investigating its effect
on the conversion of (R)-para-nitrostyrene oxide. The
obtained Ki was 122 mM. One should note that these experi-
ments were performed using racemic 1d, which implies that
the strongest inhibiting enantiomer could have an up to two-
fold lower Ki value. This implies that, for a kinetic reso-
lution with, for example, a starting concentration of
122 mM, the apparent kcat/KM is still at 50% or higher
when the preferred enantiomer is completely converted.
2.4. Activity at high substrate levels
Another limiting factor we have previously observed for
scaling up some EH-mediated resolutions was the solubility
of the substrate in the reaction medium (aqueous buffer).
If the substrate concentration exceeds its solubility, an
emulsion is formed which can quickly inactivate the
enzyme.21 Interestingly, substrates 1–3 exhibit much higher
solubilities in water (i.e. 1: 454 mM (55 g/L) at 288C) than
styrene oxide derivatives, which should avoid this limi-
tation. As 1 showed the best enantioselectivity with both
EHs, it was used to explore the possibility to achieve
conversion at high substrate concentration. Using the
ArWT EH, a substrate concentration as high as 200 mM
(24.3 g/L) still led to an excellent ee (ee .99%, c58%,
1 h reaction) of the remaining epoxide 1 after a reaction
time of about 70 min (288C) indicating that product inhi-
bition was still not predominant. At higher concentration
however, enzyme inhibition clearly occurred, thus slowing
down the reaction and affording the remaining substrate in
only very low ee (ee7%, c<12%, 6 h reaction, 250 mM).
Using the Tyr215Phe EH, the substrate concentration limit
was even slightly higher, a 95% ee being obtained at
300 mM (36.3 g/L) (c56%, 7 h reaction). Higher concen-
tration again led to enzyme inhibition. It is interesting to
emphasize the fact that, in contrast to what we observed
with the A. niger EH,14 the E-value remained constant for
both enzymes upon increase of substrate concentration.
2.5. Preparative scale conversion
Based on these results, a preparative scale conversion of 1
using both A. radiobacter EHs was carried out at a concen-
tration of 127 mM (Scheme 2). The reaction was stopped
when the ee of the residual epoxide reached a value of about
98%, as a good compromise between ee and overall yield.
Enantiomerically pure 1 could of course be obtained by
leaving the reaction proceed for some additional time.
In a typical experiment, 2 g (16.5 mmol) of rac-1 was
submitted to a BHKR procedure using 9 mg of a partially
purified enzyme extract of ArWT (specific activity for 1:
13 U/mg protein). The corresponding concentrations were,
respectively, 15.4 g/L (127 mM) of substrate and 0.07 g/L
of enzyme extract. The reaction was carried out at 288C in
130 mL phosphate buffer. After 160 min, usual work-up led
to 0.69 g (34.5% purified yield) of (S)-1—which showed an
ee of .99% and 1.3 g (R)-1d (56.6% purified yield) with an
ee of 71%. The calculated turnover number (TON) was
estimated to be about 13,200 mol substrate/mol enzyme/h
and the space time yield was about 48 g/L/day.
Similarly, a preparative scale BHKR was carried out using
the Tyr215Phe EH. Thus, 2 g (16.5 mmol) of rac-1 was
hydrolyzed using a solution of 128 mg (15.4 mL) of a
partially purified enzyme extract (specific activity for 1:
0.11 U/mg protein) at 288C in 130 mL phosphate buffer.
The corresponding concentrations were respectively
15.4 g/L (127 mM) of substrate and 0.98 g/L enzyme
extract. After 7 h and usual work-up, this led to 0.72 g
(36% purified yield) of (S)-1 which showed an ee of 98%
and 0.925 g of (R)-1d (40% purified yield) with an ee of
81%. These ee values were determined using chiral GC
analysis as described in the experimental part. The calcu-
lated turnover number (TON) was estimated to be about
360 mol substrate/mol enzyme/h and the space time yield
was about 19 g/L/day.
It is to be emphasized that, in our hands, neither of the
conventional chemistry approaches known to date (i.e. the
Table 2. Regioselectivity for the hydrolysis of 1–3 using the ArWT epoxide hydrolase and its Tyr215Phe mutant
1 2 3
EH-source a(S)/b(S)a a (R)/b(R)b eef
c a(S)/b (S) a(R)/b(R) eef a(S)/b(S) a(R)/b (R) eef
ArWT 3/97 3/97 ,0 8/92 6/94 ,0 13/87 13/87 ,0
Tyr215Phe 2/98 2/98 ,0 8/92 8/92 ,0 12/88 13/87 ,0
a a (S)/b(S): regioselectivity coefficient, a-carbon atom attack/b-carbon-atom attack of the (S)-enantiomer, given as percentages.23
b a (R)/b(R): regioselectivity coefficient, a-carbon atom attack/b-carbon-atom attack of the (R)-enantiomer, given as percentages.23
c eefenantiomeric excess of the diol at total conversion of the racemic epoxide. These values were calculated from the equation a(R)a (S)-eef as described
previously.23
Scheme 2. Preparative scale conversion of 1.
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heavy metal-based Jacobsen epoxidation or HKR strategy)
were effective under standard experimental conditions for
the preparation of enantiopure 1–3.14 This is probably due
to the low reactivity of the corresponding olefin and/or to a
complexation (or reaction) of the pyridine substrate with the
metal catalyst (or reagents).
3. Conclusions
The results we have obtained throughout this work indicate
that substrates 1–3 were efficiently and enantioselectively
hydrolyzed using the wild-type epoxide hydrolase from the
bacteria A. radiobacter as well as by its Tyr215Phe mutant.
The wild type enzyme clearly showed a so-called sequential
mechanism for all three epoxides, as already observed with
other substrates, while in contrast the Tyr215Phe mutant
exhibited a classical kinetic profile. These results show that
the active-site mutation introduced into the Agrobacterium
enzyme on basis of the X-ray structure has yielded a more
suitable catalyst for various kinetic resolutions, making the
enzyme more versatile. Since Tyr215 is conserved in other
epoxide hydrolase sequences, it is well conceivable that the
same mutation can also be used to improve the applicability
of other epoxide hydrolases.
The enantio- and regioselectivity of these BHKR were
determined. As expected from previous observations, the
mutant enzyme exhibited a slight increase in enantio-
selectivity and both enzymes showed the same regioselec-
tivity. Interestingly, in contrast to the previously observed
results using the same enzymes but different substrates,
2-pyridyloxirane 1 could be operated at concentrations as
high as 200 mM for the wild-type epoxide hydrolase and up
to 300 mM for the mutant enzyme. These were used to
achieve a preparative scale synthesis of enantiopure (S)-1
(ee.99%) at a 127 mM (15.4 g/L) concentration. Due to the
fact that conventional chemistry approaches, including the
Jacobsen HKR cobalt-based catalyst, were not successful in
our hands, these results, together with those obtained using
the Aspergillus niger epoxide hydrolase, are particularly
interesting from the ‘chirotechnology’ point of view.
Work is in progress in our laboratories in order to widen




For gas chromatographic analysis, the chiral columns
Chiralsil Dex CB (Chrompack) and Lipodex E (Macherey
and Nagel) were used. This allowed to determine the ee of
1–3. The enzyme solutions were prepared as described by
Rink et al.16 The synthesis of 1–3 and 1d–3d have been
described.14
4.1.1. Determination of the ee of 2-pyridyldiol 1d by
derivatisation to the dimethylether. The ee was deter-
mined by adding 100 mL DMSO, KOH and 12 mL iodo-
methane to the dry diol. This was stirred for 30 min at
RT. The formed dimethylether was extracted with diethyl-
ether and analyzed by GC (col. Lipodex E, 908C; 23 and
25 min).
4.1.2. Determination of inhibition constants. The com-
petitive inhibition constant Ki of diol 1d to the Ty215Phe
mutant was obtained from depletion curves of (R)-para-
nitrostyrene oxide with varying concentrations of racemic
diol. The apparent kcat/Km values, (kcat/Km)
app were deter-
mined by fitting a single exponential to the depletion curves.
The inhibition constant Ki was obtained by fitting the
formula (kcat/KM)
app(kcat/KM)/(11[1d]/Ki) to the (kcat/
KM)
app values, using several concentrations of 1d.24
4.2. General procedure for biohydrolysis of 1.
Preparative scale conversion
An amount of 2 g (16.5 mmoles) of rac-epoxide 1 was
dissolved in 0.1 M Na-phosphate buffer pH8. The total
volume together with the added enzyme solution
(1.29 mL; 0.07 g/L inTris-buffer pH9 for ArWT and
15.4 mL; 8.3 g/L in Tris-buffer pH9 for the Tyr215Phe
mutant) was 130 mL (288C; 250 rpm). The reaction was
stopped at ee.98% by extracting the epoxide with CHCl3.
The aqueous phase was then lyophilized, and 1d was
directly extracted with acetone from the resulting dry diol-
salt and purified by flash chromatography. From the CHCl3
phase the epoxide and the diol were purified by flash
chromatography: epoxide: pentane/ethylacetate 4/6; diol:
ethylacetate/methanol: 9/1. The fractions containing the
epoxide and respectively the diol were pooled, dried over
Na2SO4, and the solvent was removed by stripping. The
fractions containing the diol were treated similarly. The
epoxide was further purified by bulb-to-bulb distillation
(4£1022 mbar, 408C).
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